GENNEX LABORATORIES LTD. Share Price

GENNEX LABORATORIES LTD. Share Price

BSE: 531739
|
Pharmaceuticals
|
S Cap
₹ 10.17
-₹0.11 (-1.07%)
1D
Last updated 22 Sep, 2026, 15:28 IST

GENNEX LABORATORIES LTD. Share Price Today

As of 23 Sep 2026, GENNEX LABORATORIES LTD. share price is ₹10.17. The stock opened at ₹10.25, compared to its previous close of ₹10.28. During today's trading session, GENNEX LABORATORIES LTD. share price moved in the range of ₹10.14 to ₹10.45, with an average price of ₹10.29 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.05 and a high of ₹17.25.

₹10.14
1.07% down today
₹10.45
1D LOW
1D HIGH

GENNEX LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹8.17
₹12.25
52-week
L
H
₹7.05
₹17.25

About GENNEX LABORATORIES LTD.

GENNEX LABORATORIES LTD. Share Price
ISIN
INE509C01026
Sector Market Cap
₹ 249.75 Cr

Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.

GENNEX LABORATORIES LTD. Financial Highlights

  • Revenue: GENNEX LABORATORIES LTD. reported revenue of ₹180.99 crore in FY26 vs ₹158.76 crore in FY25. It showed an increase of 14.00% on a yearly basis.
  • Operating Profit: GENNEX LABORATORIES LTD. reported an operating profit of ₹23.24 crore in FY26 vs ₹21.40 crore in FY25. It showed an increase of 8.60% on a year-on-year basis.
  • Net Profit: GENNEX LABORATORIES LTD. reported a net profit of ₹20.98 crore in FY26 vs ₹18.12 crore in FY25. It showed an increase of 15.78% on a yearly basis.

GENNEX LABORATORIES LTD. Quarterly Result Highlights

  • GENNEX LABORATORIES LTD. reported revenue of ₹41.85 crore in Jun 2026, compared with ₹62.28 crore in Mar 2026, representing a decrease of 32.80% on a quarter-on-quarter (QoQ) basis.
  • GENNEX LABORATORIES LTD. reported an operating profit of ₹4.92 crore in Jun 2026, compared with ₹4.67 crore in Mar 2026, representing an increase of 5.35% on a quarter-on-quarter (QoQ) basis.
  • GENNEX LABORATORIES LTD. reported a profit of ₹4.67 crore in Jun 2026, compared with ₹4.46 crore in Mar 2026, reflecting an increase of 4.71% on a QoQ basis.
  • The earnings per share (EPS) of GENNEX LABORATORIES LTD. stood at ₹0.80 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
23.63%
FII
0.00%
Other DII
0.00%
Retail and other
76.37%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
249.75
P/E
12.01
P/B
1.11
ROE
8.29%
D/E
0.10
ROCE
9.09%
Div. Yield
0.00%
EPS(TTM)
0.67
Turnover
0.47
EV/EBITDA
9.50
Net Margin
0.00%
Op. Margin
0.00%
ROA
5.92%
Quick Ratio
0.00
Curr. Ratio
8.14
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Gennex Lab. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Gennex Lab. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Gennex Lab. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GENNEX LABORATORIES LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹137.90₹86.71₹65.60₹61.21
Other Income₹10.43₹4.91₹3.95₹1.38
Total Revenue₹148.33₹91.62₹69.56₹62.60
Total Expenses₹126.79₹75.13₹63.18₹57.50
Profit Before Tax₹21.40₹16.49₹6.37₹5.09
Tax₹3.27₹3.32₹1.45₹1.17
Profit After Tax₹18.12₹13.18₹4.92₹3.92
EPS - Basic₹0.80₹0.67₹0.32₹0.33
EPS - Diluted₹0.80₹0.61₹0.32₹0.33

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹21.40₹16.49₹6.37₹5.28
Income before WC changes₹17.43₹18.14₹5.98₹7.84
Change in Assets-₹24.75-₹66.88₹5.25-₹0.30
Change in Liabilities-₹0.25₹2.05₹12.45₹5.47
Change in WC-₹25.00-₹64.83₹17.69₹5.18
Cash flow from Operations-₹10.80-₹46.69₹23.68₹11.91
Cash flow from Investing₹0.82₹18.91-₹38.33-₹2.47
Cash flow from Financing₹4.57₹73.68₹21.03-₹1.83
Total Cash Flow-₹5.41₹45.91₹6.38₹7.61
Cash (Start of the year)₹60.98₹15.06₹8.68₹1.07
Cash (End of the year)₹55.57₹60.98₹15.06₹8.68

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹74.91₹68.17₹83.63₹20.84
Current Assets₹181.13₹161.81₹48.68₹47.18
Total Assets₹256.04₹229.99₹132.32₹68.03
Current Liabilities₹44.56₹40.30₹29.51₹24.21
Net Current Asset₹136.57₹121.51₹19.17₹22.97
Non-Current Liabilities₹16.89₹13.22₹16.29₹0.00
Equity Capital₹194.59₹176.46₹86.52₹43.82
Total Equity & Liabilities₹256.04₹229.99₹132.32₹68.03

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹94.58₹66.80₹65.10₹61.21
Other Income₹9.22₹4.30₹3.40₹1.38
Total Revenue₹103.80₹71.10₹68.50₹62.60
Total Expenses₹86.59₹56.35₹62.49₹57.50
Profit Before Tax₹17.06₹14.75₹6.01₹5.09
Tax₹3.02₹2.96₹1.45₹1.17
Profit After Tax₹14.04₹11.80₹4.56₹3.92
EPS - Basic₹0.62₹0.69₹0.31₹0.31
EPS - Diluted₹0.62₹0.69₹0.31₹0.31

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹17.06₹14.87₹6.01₹5.28
Income before WC changes₹11.02₹13.06₹5.28₹7.84
Change in Assets-₹13.43-₹60.48-₹19.00-₹2.31
Change in Liabilities-₹7.11₹15.08-₹0.72₹2.21
Change in WC-₹20.54-₹45.40-₹19.73-₹0.10
Cash flow from Operations-₹9.52-₹33.43-₹14.45₹6.64
Cash flow from Investing₹2.63₹0.93-₹0.77-₹1.26
Cash flow from Financing₹1.53₹79.01₹21.35₹1.87
Total Cash Flow-₹5.36₹46.51₹6.14₹7.24
Cash (Start of the year)₹60.96₹14.45₹8.31₹1.07
Cash (End of the year)₹55.60₹60.96₹14.45₹8.31

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹31.36₹26.35₹24.06₹21.03
Current Assets₹187.02₹178.99₹72.16₹47.18
Total Assets₹218.38₹205.34₹96.22₹68.21
Current Liabilities₹29.11₹32.82₹15.91₹24.21
Net Current Asset₹157.91₹146.17₹56.25₹22.97
Non-Current Liabilities₹4.47₹1.76₹1.29₹0.00
Equity Capital₹184.80₹170.76₹79.02₹44.00
Total Equity & Liabilities₹218.38₹205.34₹96.22₹68.21
* All values are in INR Crore
Qty
Bid
838
10.21
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 838
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.91
Neutral
ATR (14)
0.62
Neutral
STOCH(9,6)
11.23
Bullish
STOCH RSI (14)
14.23
Bullish
ADX(9)
39.63
Bearish
UO(9)
36.69
Neutral
ROC(12)
-13.47
Bearish
WillR(14)
-91.18
Bullish
Period
Simple value
Exponential vaue
5D
10.36
10.38
10D
10.7
10.69
20D
11.48
10.95
50D
10.42
10.78
100D
10.47
10.72
Volume trend — traded volume by day
22 Sep1L
21 Sep3L
18 Sep3L
17 Sep1L
16 Sep3L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GENNEX LABORATORIES LTD. Share Price
GENNEX LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

GENNEX LABORATORIES LTD. Share Price FAQs

GENNEX LABORATORIES LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837